| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5439689 | BAUSCH | Diltiazem formulation |
Aug, 2012
(11 years ago) | |
Cardizem Cd is owned by Bausch.
Cardizem Cd contains Diltiazem Hydrochloride.
Cardizem Cd has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Cardizem Cd are:
- US5439689
Cardizem Cd was authorised for market use on 10 August, 1992.
Cardizem Cd is available in capsule, extended release;oral dosage forms.
Cardizem Cd can be used as treatment of hypertension and angina pectoris.
The generics of Cardizem Cd are possible to be released after 08 August, 2012.
Drugs and Companies using DILTIAZEM HYDROCHLORIDE ingredient
Market Authorisation Date: 10 August, 1992
Treatment: Treatment of hypertension and angina pectoris
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of CARDIZEM CD before it's drug patent expiration?
More Information on Dosage
CARDIZEM CD family patents
